ReviewCancer immunology, immunotherapy : CII2012

TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers.

Kelly Barrios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.